Obese Children With Nonalcoholic Fatty Liver Disease at Greater Risk of High Blood Pressure

Researchers at University of California, San Diego School of Medicine have found obese children suffering from nonalcoholic fatty liver disease (NAFLD) are at an increased risk of suffering from high blood pressure and this is commonly not diagnosed, a new study published in the journal PLOS ONE reveals.

"As a result of our study, we recommend that blood pressure evaluation, control and monitoring should be included as an integral component of the clinical management of children with NAFLD, especially because this patient population is at greater risk for heart attacks and strokes," said Jeffrey Schwimmer, MD, in the Department of Pediatrics at UC San Diego School of Medicine and principal investigator of the study. "Hypertension is a main cause of preventable death and disability in the United States in adults, but much of the origin occurs in childhood."

Childhood Obesity - Criteria - Causes - Complications, Treatment
Childhood obesity is one of the most serious health challenges in the developing countries and needs to be understood and tackled effectively.

NAFLD - the inappropriate storage of fat droplets inside liver cells - is the most common cause of chronic liver disease in the United States and affects nearly 10 percent of all children. Although children with chronic liver disease often have no symptoms, some children with NAFLD will have fatigue and/or abdominal pain. The initial evaluation for NAFLD is via a blood test and diagnosis is ultimately based upon a liver biopsy. The disease is most common in children and teenagers who are overweight and can develop in conjunction with other health problems, such as diabetes.

The study, conducted by the National Institutes of Health Nonalcoholic Steatohepatitis Clinical Research Network, enrolled 484 children with NAFLD between two-and-17-years-old. The participants'' blood pressure was assessed at enrollment and at 48 weeks. Nearly 36 percent of the group had high blood pressure at baseline; 21 percent had persistent high blood pressure almost a year later. In comparison, high blood pressure was present in two to five percent of all children and 10 percent of obese children.

"Along with being at an increased risk for cardiovascular disease, we found that children with NAFLD who had high blood pressure were significantly more likely to have more fat in their liver than children without high blood pressure. This could lead to a more serious form of liver disease," said Schwimmer.

Age Related Macular Degeneration (AMD) - Causes, Symptoms, Diagnosis, Treatment & Prevention
Age related macular degeneration is a disease of the elderly, wherein the macula or the central part of the retina gets affected, leading to loss of vision.

Researchers also found that compared to boys, girls with NAFLD were significantly more likely to have persistent high blood pressure.

Currently, there are no approved and effective treatments for children with NAFLD. However, there are treatments for high blood pressure.

Atkins Diet - Basic Principle Stages Foodmanual Advantage Disadvantage FAQs
Atkins diet is a low carbohydrate diet and aids in weight loss. It was developed by Robert Atkins.

"There are some reasons to believe that blood pressure control could be beneficial for NAFLD. Thus, we may be able to decrease the risk of premature cardiovascular disease in these children, and also help their liver," said Schwimmer. "Parents and doctors need to be aware of the health risks of children who have NAFLD. The sooner high blood pressure is identified and treated in this patient population, the healthier they will be as they transition into adulthood."

Co-authors include Anne Zepeda and Kimberly P. Newton, UC San Diego; Cynthia Behling, Sharp Medical Center; Erin K. Hallinan, Michele Donithan and James Tonascia, Johns Hopkins Bloomberg School of Public Health; and Stavra A. Xanthakos, Cincinnati Children''s Hospital Medical Center.

The study was supported in part by the NASH Clinical Research Network and the National Institute of Diabetes and Digestive and Kidney Diseases (grants U01DK061718, U01DK061728, U01DK061731, U01DK061732, U01DK061734, U01DK061737, U01DK061738, U01DK061730, U01DK061713); the National Center for Advancing Translational Sciences (grants UL1TR000439, UL1TR000077, UL1TR000436, UL1TR000150, UL1TR000424, UL1TR000006, UL1TR000448, UL1TR000040, UL RR031980, UL1TR000100, UL1TR000004, UL1TR000423, UL1TR000058, UL1TR000067, UL1TR000454); and the National Institute of Child Health and Human Development and the National Cancer Institute (grant 8TL1TR000098-03).

Source-Newswise